pyridine-2-carboxaldehyde has been researched along with Breast Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hueso-Ureña, F; Illán-Cabeza, NA; Jiménez-Pulido, SB; Martínez-Martos, JM; Moreno-Carretero, MN; Ramírez-Expósito, MJ; Sánchez-Sánchez, P | 1 |
1 other study(ies) available for pyridine-2-carboxaldehyde and Breast Neoplasms
| Article | Year |
|---|---|
Effects on estrogen-dependent and triple negative breast cancer cells growth of Ni(II), Zn(II) and Cd(II) complexes with the Schiff base derived from pyridine-2-carboxaldehyde and 5,6-diamino-1,3-dimethyluracil explored through the renin-angiotensin syste
Topics: Aldehydes; Aminopeptidases; Breast Neoplasms; Cadmium; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Estrogens; Humans; Molecular Structure; Neoplasms, Hormone-Dependent; Nickel; Pyridines; Renin-Angiotensin System; Schiff Bases; Triple Negative Breast Neoplasms; Uracil; Zinc | 2018 |